Physician profile
Mark A Jones
NPI 1801867346
$1,385.58
in general payments reported to CMS, 2019-2025
16 companies · $76.27 in 2025
The $76.27 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $84.19 · 2021: $13.24 · 2022: $144 · 2023: $131 · 2024: $665 · 2025: $76.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $467 · Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $466.86 |
| Food and Beverage | $405.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $594.28 | 2024 | Stealthstation S8 Platform, Micra |
| Akcea Therapeutics, INC. | $155.62 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $147.27 | 2019-2022 | |
| Boston Scientific Corporation | $136.46 | 2022-2023 | Watchman Access System |
| Amgen INC. | $79.56 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $58.36 | 2020-2022 | |
| Novo Nordisk INC | $38.17 | 2023 | Ozempic |
| Novartis Pharmaceuticals Corporation | $35.93 | 2020-2025 | |
| Kerecis Limited | $25.20 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Coherus Oncology, INC. | $23.34 | 2025 | Loqtorzi |
| Pfizer INC. | $17.98 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.64 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $15.12 | 2024 | |
| Merck Sharp & Dohme LLC | $14.72 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $13.75 | 2023 | Wainua |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $13.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.